NASDAQ:BBH

VanEck Vectors Biotech ETF News Headlines

$185.99
+2.54 (+1.38 %)
(As of 04/16/2021 04:00 PM ET)
Add
Compare
Today's Range
$183.58
Now: $185.99▼
$185.99
50-Day Range
$167.43
MA: $175.72▼
$183.45
52-Week Range
$138.59
Now: $185.99▼
$197.28
Volume10,379 shs
Average Volume12,847 shs
Market Capitalization$524.86 million
P/E RatioN/A
Dividend Yield0.34%
Beta1.01

Headlines

VanEck Vectors Biotech ETF (NASDAQ BBH) News Headlines Today

SourceHeadline
Biotech ETFs Make Gains Tuesday, Despite the J&J Vaccine PauseBiotech ETFs Make Gains Tuesday, Despite the J&J Vaccine Pause
nasdaq.com - April 13 at 7:51 PM
VanEck Vectors Biotech ETF (NASDAQ:BBH) Sees Large Decrease in Short InterestVanEck Vectors Biotech ETF (NASDAQ:BBH) Sees Large Decrease in Short Interest
americanbankingnews.com - April 2 at 3:16 AM
How to Improve The Timing of Investment Decisions in Van Eck Vectors Biotech Etf $BBHHow to Improve The Timing of Investment Decisions in Van Eck Vectors Biotech Etf $BBH
marketwatch.com - March 24 at 10:47 AM
Biotech Shined with Vaccines. It Can Do It Again with ‘BBH’Biotech Shined with Vaccines. It Can Do It Again with ‘BBH’
nasdaq.com - March 3 at 4:23 PM
Illumina Earnings, Forward Guidance Strengthen Biotech ETFsIllumina Earnings, Forward Guidance Strengthen Biotech ETFs
nasdaq.com - February 12 at 5:26 PM
IPOs Are Back. Get In On the Action with the BBH ETFIPOs Are Back. Get In On the Action with the BBH ETF
nasdaq.com - February 9 at 2:51 PM
Novavax (NVAX) ETFs to Rise on Impressive Coronavirus Vaccine UpdateNovavax (NVAX) ETFs to Rise on Impressive Coronavirus Vaccine Update
nasdaq.com - January 29 at 5:29 PM
Biotech Surge – COVID-19 Cure is Just the StartBiotech Surge – COVID-19 Cure is Just the Start
nasdaq.com - January 3 at 9:10 AM
Bullish on Biotech? The BBH ETF is Not Just a 2020 PlayBullish on Biotech? The BBH ETF is Not Just a 2020 Play
nasdaq.com - November 19 at 5:14 PM
VanEck Vectors Biotech ETF (BBH)VanEck Vectors Biotech ETF (BBH)
nasdaq.com - October 29 at 5:57 PM
Late-Stage Coronavirus Vaccine Trials Begin: Biotech ETFs to GainLate-Stage Coronavirus Vaccine Trials Begin: Biotech ETFs to Gain
finance.yahoo.com - July 28 at 3:21 PM
Biotech ETFs to Shine on Pfizers Coronavirus Vaccine ProgressBiotech ETFs to Shine on Pfizer's Coronavirus Vaccine Progress
www.nasdaq.com - July 14 at 7:07 PM
Biotech ETFs to Gain as Coronavirus Vaccine Hopes StrengthenBiotech ETFs to Gain as Coronavirus Vaccine Hopes Strengthen
www.nasdaq.com - July 3 at 12:33 PM
New Pharma ETF Focuses on Testing and Treatment for Infectious Diseases--but Not Covid-19New Pharma ETF Focuses on Testing and Treatment for Infectious Diseases--but Not Covid-19
finance.yahoo.com - June 28 at 5:18 PM
Race for Coronavirus Vaccine Heats Up: Biotech ETFs to GainRace for Coronavirus Vaccine Heats Up: Biotech ETFs to Gain
www.nasdaq.com - May 27 at 12:35 PM
Biotech ETFs Poised to Benefit From CoronavirusBiotech ETFs Poised to Benefit From Coronavirus
finance.yahoo.com - May 7 at 5:54 AM
Biotech Stocks & ETFs to Gain on Progress in COVID-19 Vaccine DevelopmentBiotech Stocks & ETFs to Gain on Progress in COVID-19 Vaccine Development
finance.yahoo.com - April 1 at 10:10 PM
VanEck Vectors Biotech ETF (BBH) After-Hours QuotesVanEck Vectors Biotech ETF (BBH) After-Hours Quotes
www.nasdaq.com - February 12 at 7:24 PM
VanEck Vectors Biotech ETF (BBH) Real-Time QuotesVanEck Vectors Biotech ETF (BBH) Real-Time Quotes
www.nasdaq.com - February 12 at 7:24 PM
Can Biotech ETFs Gain on Mixed Q4 Earnings Results?Can Biotech ETFs Gain on Mixed Q4 Earnings Results?
www.msn.com - February 11 at 6:10 PM
VAREX IMAGING (VREX) Q1 Earnings Miss EstimatesVAREX IMAGING (VREX) Q1 Earnings Miss Estimates
finance.yahoo.com - February 11 at 6:10 PM
The Top Biotech ETFs to Watch in 2020The Top Biotech ETFs to Watch in 2020
www.msn.com - January 3 at 3:06 PM
VanEck Vectors Biotech ETF declares annual distribution of $0.4724VanEck Vectors Biotech ETF declares annual distribution of $0.4724
seekingalpha.com - December 20 at 11:37 PM
VanEck Vectors Biotech ETF declares annual distribution of $0.4160VanEck Vectors Biotech ETF declares annual distribution of $0.4160
seekingalpha.com - November 27 at 5:51 PM
VanEck Vectors Biotech ETFVanEck Vectors Biotech ETF
www.thestreet.com - March 19 at 3:46 PM
Biotech Is Worth The Hype, But Do You Have The Data?Biotech Is Worth The Hype, But Do You Have The Data?
seekingalpha.com - March 2 at 3:31 PM
Why 6 Top Biotech Stocks Could Beat Wall Street Q4 EstimatesWhy 6 Top Biotech Stocks Could Beat Wall Street Q4 Estimates
247wallst.com - January 31 at 9:33 AM
Bristol-Myers to Acquire Celgene: Healthcare ETFs in FocusBristol-Myers to Acquire Celgene: Healthcare ETFs in Focus
finance.yahoo.com - January 4 at 3:23 PM
This page was last updated on 4/17/2021 by MarketBeat.com Staff

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.